Quit Smoking, Indonesia
Quit Smoking, Indonesia @beautyindonesia_com: Quit/stop smoking with the medication ChampixŽ. Smoking cessation clinic, Indonesia. Private and confidential services. Definitions, references, and latest news.
Quit smoking with the medication Champix®. Revolutionary new way to stop smoking at our smoking cessation clinic. Get away from the harmful effects of smoking, without feeling the effects of withdrawal!
| Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic: |
| SHIM CLINIC|
168 Bedok South Avenue 3 #01-473
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Quit Smoking, Indonesia
| Opening Hours |
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.
Role of nicotine receptor partial agonists in tobacco cessation.
Fri, 28 Feb 2014 17:56:51 +0100 | Indian Journal of Psychiatry
Authors: Maity N, Chand P, Murthy P
Nicotinic receptor antagonists as treatments for nicotine abuse.
Tue, 11 Feb 2014 00:40:03 +0100 | Advances in Pharmacology
Authors: Crooks PA, Bardo MT, Dwoskin LP
Nicotine Administration in the Cholinergic Basal Forebrain Increases Alcohol Consumption in C57BL/6J Mice
Tue, 11 Feb 2014 00:00:00 +0100 | Alcoholism: Clinical and Experimental Research
ConclusionsBased on our results, we believe that the BF may have an important role in nicotineâalcohol coâuse. (Source: Alcoholism: Clinical and Experimental Research)
Nicotine Administration in the Cholinergic Basal Forebrain Increases Alcohol Consumption in C57BL/6J Mice.
Tue, 11 Feb 2014 00:00:00 +0100 | Alcoholism, Clinical and Experimental Research
CONCLUSIONS: Based on our results, we believe that the BF may have an important role in nicotine-alcohol co-use.
More Evidence Varenicline Helps Mentally Ill Quit SmokingMore Evidence Varenicline Helps Mentally Ill Quit Smoking
Mon, 10 Feb 2014 19:20:52 +0100 | Medscape Psychiatry Headlines
Varenicline helps smokers with serious mental illness abstain from smoking, new research shows. But at least 1 expert is still not entirely convinced of its safety in this patient population. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Sat, 08 Feb 2014 02:26:20 +0100 | Clinics in Chest Medicine
Cigarette smoking is a major preventable cause of morbidity and mortality. It is the major risk factor for chronic obstructive pulmonary disease in the developed world. Smoking is a chronic relapsing disease. Optimal treatment includes nonpharmacologic support, together with pharmacotherapy. All clinicians should be comfortable with the use of nicotine replacement therapy, bupropion, and varenicline. Second-line therapies can be used by those familiar with their use. Effective use of these medications requires their integration into an effective management plan, which is likely to be a long-term undertaking, involving several cycles of remission and relapse. (Source: Clinics in Chest Medicine)
The longâterm costâeffectiveness of varenicline (12âweek standard course and 12Â +Â 12âweek extended course) vs. other smoking cessation strategies in Canada
Wed, 29 Jan 2014 05:00:00 +0100 | International Journal of Clinical Practice
ConclusionsThe standard and extended courses of varenicline are decidedly costâeffective treatment regimes compared with alternative smoking cessation interventions and can provide significant cost savings to the healthcare system. (Source: International Journal of Clinical Practice)
Unique pharmacology of heteromeric Îą7Î˛2 nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes.
Tue, 28 Jan 2014 00:00:00 +0100 | European Journal of Pharmacology
Authors: Zwart R, Strotton M, Ching J, Astles PC, Sher E
Varenicline may reduce negative effect while aiding smoking cessation
Wed, 22 Jan 2014 05:00:00 +0100 | Evidence-Based Medicine
Commentary on: Cinciripini PM, Robinson JD, Karam-Hage M, et al.. Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal. JAMA Psychiatry 2013;70:522–33. Context Cigarette smoking remains the most important cause of preventable morbidity and premature mortality, with projected annual tobacco-attributable deaths worldwide estimated to reach nearly 6.5 million by 2015.1 The most effective treatment for tobacco dependence is combined behavioural and pharmacological therapy, which is widely available yet underemployed. Most attempts to quit smoking are still unaided, and surveys suggest that pharmacological treatment is often n...
Safety of Varenicline in Patients With Cardiovascular Disease
Thu, 16 Jan 2014 05:00:00 +0100 | Journal of Pharmacy Practice
Smoking cessation lowers the risk of death substantially in patients with cardiovascular disease. Although varenicline is an effective medication for smoking cessation, its safety in this population has been questioned and evaluated in several studies. In 2 randomized controlled trials of patients with cardiovascular disease, the rates of serious cardiovascular events were up to 2% higher in patients receiving varenicline than placebo, though the differences were not statistically significant. In the first meta-analysis of mostly trials involving patients with a history of cardiovascular disease, varenicline was found to significantly increase the risk of cardiovascular events by 72%; however, a second meta-analysis did not find a significant increased risk. In an observational study, vare...